<?xml version="1.0" encoding="UTF-8"?>

<Composition xmlns="http://hl7.org/fhir">
  <id value="gravitate-Cecilia"/>
  <text>
    <status value="extensions"/><div xmlns="http://www.w3.org/1999/xhtml">
  
    <b>Id:</b>
    gravitate-Cecilia
  <br/>
  
    <b>status:</b>
    final
  <br/>
  
    <b>Type:</b>
    Patient summary Document
  <br/>
  
    <b>Subject:</b>
    <a>Cecilia Gravitate</a>
  

  <br/>
  <b>Sections:</b>
  <br/>

  <ul>
    
      <li>

        Problem List

      </li>
      <ul>

        

          <li>

            COPD

          </li>
        

          <li>

            Diabetese Type 2

          </li>
        

          <li>

            Osteoporosis

          </li>
        

          <li>

            Congestive Heart Failure

          </li>
        
      </ul>

    
      <li>

        Medication Summary

      </li>
      <ul>

        

          <li>

            Fosamax 70 mg tablets

          </li>
        

          <li>

            Monuril 3 g granules for oral solution

          </li>
        

          <li>

            Oxymetazoline hydrochloride  0.05 mg / 1 ml Spray

          </li>
        
      </ul>

    
  </ul>
</div>
  </text>
  <status value="final"/>
  <type>
    <coding>
      <system value="http://loinc.org"/>
      <code value="60591-5"/>
      <display value="Patient summary Document"/>
    </coding>
  </type>
  <subject>
    <reference value="Patient/cecilia-patient"/>
    <display value="Cecilia Gravitate"/>
  </subject>
  <date value="2018-07-10T15:22:00+02:00"/>
  <author>
    <reference value="Practitioner/cecilia-pract"/>
    <display value="Dr. Anna Karlsson"/>
  </author>
  <title value="Patient Summary (Cecilia Gravitate)"/>
  <confidentiality value="N"/>
  <section>
    <title value="Problem List"/>
    <code>
      <coding>
        <system value="http://loinc.org"/>
        <code value="11450-4"/>
        <display value="Problem list Reported"/>
      </coding>
    </code>
    <text>
      <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><ul><li>COPD</li><li>Diabetes type 2</li><li>Osteoporosis</li><li>Congestive Heart Failure</li></ul></div>
    </text>
    <entry>
      <reference value="urn:uuid:7b69285e-bf3a-4b8d-a30f-8effd6059a4f"/>
      <display value="COPD"/>
    </entry>
    <entry>
      <reference value="urn:uuid:0d4addd6-c3ee-468c-9202-026a24293f32"/>
      <display value="Diabetese Type 2"/>
    </entry>
    <entry>
      <reference value="urn:uuid:c2a8ea98-cf92-4f57-933c-7d857fb20b1d"/>
      <display value="Osteoporosis"/>
    </entry>
    <entry>
      <reference value="urn:uuid:ebb1a59f-a249-40dd-9868-25879bc9bb71"/>
      <display value="Congestive Heart Failure"/>
    </entry>
  </section>
  <section>
    <title value="Medication Summary"/>
    <code>
      <coding>
        <system value="http://loinc.org"/>
        <code value="10160-0"/>
        <display value="Hx of Medication use"/>
      </coding>
    </code>
    <text>
      <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><table><thead><tr><th>Brand Name</th><th>MAN</th><th>Active Substance</th><th>Common Name</th><th>ATC</th><th>Strength</th><th>Dose Form</th><th>RoA</th></tr></thead><tbody><tr><td>Skilarence</td><td>EU/1/17/1201/001</td><td>dimethyl fumarate (FO2303MNI2)</td><td>dimethyl fumarate</td><td>L04AX07</td><td>30 mg</td><td>Gastro-resistant tablet</td><td>Oral use</td></tr><tr><td>Karvea</td><td>EMEA/H/C/000142</td><td>irbesartan (J0E2756Z7N)</td><td>irbesartan</td><td>C09DA04</td><td>75 mg</td><td>Tablet</td><td>Oral use</td></tr><tr><td>Boots Decongestant 0.05% w/v Nasal spray</td><td>PL 16028/0049</td><td>oxymetazoline hydrochloride (K89MJ0S5VY)</td><td>oxymetazoline hydrochloride</td><td>R01AA05</td><td>0.05 mg / 1 ml</td><td>Nasal spray, solution</td><td>Nasal use</td></tr></tbody></table></div>
    </text>
    <entry>
      <reference value="MedicationStatement/cecilia-med-stat-1"/>
      <display value="Fosamax 70 mg tablets"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/cecilia-med-stat-2"/>
      <display value="Monuril 3 g granules for oral solution"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/cecilia-med-stat-3"/>
      <display value="Oxymetazoline hydrochloride  0.05 mg / 1 ml Spray"/>
    </entry>
  </section>
</Composition>